Principles of diffusion kurtosis imaging and its role in early diagnosis of neurodegenerative disorders
- PMID: 29378223
- DOI: 10.1016/j.brainresbull.2018.01.015
Principles of diffusion kurtosis imaging and its role in early diagnosis of neurodegenerative disorders
Abstract
Pathology of neurodegenerative diseases can be correlated with intra-neuronal as well as extracellular changes which lead to neuronal degeneration. The central nervous system (CNS) is a complex structure comprising of many biological barriers. These microstructural barriers might be affected by a variety of pathological processes. Specifically, changes in the brain tissue's microstructure affect the diffusion of water which can be assessed non-invasively by diffusion weighted (DW) magnetic resonance imaging (MRI) techniques. Diffusion tensor imaging (DTI) is a diffusion MRI technique that considers diffusivity as a Gaussian process, i.e. does not account for any diffusion hindrance. However, environment of the brain tissues is characterized by a non-Gaussian diffusion. Therefore, diffusion kurtosis imaging (DKI) was developed as an extension of DTI method in order to quantify the non-Gaussian distribution of water diffusion. This technique represents a promising approach for early diagnosis of neurodegenerative diseases when the neurodegenerative process starts. Hence, the purpose of this article is to summarize the ongoing clinical and preclinical research on Parkinson's, Alzheimer's and Huntington diseases, using DKI and to discuss the role of this technique as an early stage biomarker of neurodegenerative conditions.
Keywords: Alzheimer’s disease; Diffusion kurtosis imaging; Huntington’s disease; Neurodegenerative disorders; Neuroimaging; Parkinson’s disease.
Copyright © 2018 Elsevier Inc. All rights reserved.
Similar articles
-
Differences in Gaussian diffusion tensor imaging and non-Gaussian diffusion kurtosis imaging model-based estimates of diffusion tensor invariants in the human brain.Med Phys. 2016 May;43(5):2464. doi: 10.1118/1.4946819. Med Phys. 2016. PMID: 27147357
-
Diffusion Magnetic Resonance Imaging-Based Biomarkers for Neurodegenerative Diseases.Int J Mol Sci. 2021 May 14;22(10):5216. doi: 10.3390/ijms22105216. Int J Mol Sci. 2021. PMID: 34069159 Free PMC article. Review.
-
MR diffusion kurtosis imaging for neural tissue characterization.NMR Biomed. 2010 Aug;23(7):836-48. doi: 10.1002/nbm.1506. NMR Biomed. 2010. PMID: 20623793 Review.
-
MR Biomarkers of Degenerative Brain Disorders Derived From Diffusion Imaging.J Magn Reson Imaging. 2020 Dec;52(6):1620-1636. doi: 10.1002/jmri.27019. Epub 2019 Dec 13. J Magn Reson Imaging. 2020. PMID: 31837086 Free PMC article. Review.
-
Can diffusion kurtosis imaging improve the sensitivity and specificity of detecting microstructural alterations in brain tissue chronically after experimental stroke? Comparisons with diffusion tensor imaging and histology.Neuroimage. 2014 Aug 15;97:363-73. doi: 10.1016/j.neuroimage.2014.04.013. Epub 2014 Apr 15. Neuroimage. 2014. PMID: 24742916
Cited by
-
Role of diffusion kurtosis imaging in evaluating microstructural changes in spinal cord of patients with cervical spondylosis.Eur Spine J. 2023 Mar;32(3):986-993. doi: 10.1007/s00586-023-07559-x. Epub 2023 Feb 4. Eur Spine J. 2023. PMID: 36738338
-
Machine Learning Based on Diffusion Kurtosis Imaging Histogram Parameters for Glioma Grading.J Clin Med. 2022 Apr 21;11(9):2310. doi: 10.3390/jcm11092310. J Clin Med. 2022. PMID: 35566437 Free PMC article.
-
Microstructural Changes in the Corpus Callosum in Neurodegenerative Diseases.Cureus. 2024 Aug 21;16(8):e67378. doi: 10.7759/cureus.67378. eCollection 2024 Aug. Cureus. 2024. PMID: 39310519 Free PMC article. Review.
-
Early Stage Markers of Late Delayed Neurocognitive Decline Using Diffusion Kurtosis Imaging of Temporal Lobe in Nasopharyngeal Carcinoma Patients.J Cancer. 2020 Aug 25;11(20):6168-6177. doi: 10.7150/jca.48759. eCollection 2020. J Cancer. 2020. PMID: 32922556 Free PMC article.
-
A comparative study of functional MRI in predicting response of regional nodes to induction chemotherapy in patients with nasopharyngeal carcinoma.Front Oncol. 2022 Aug 31;12:960490. doi: 10.3389/fonc.2022.960490. eCollection 2022. Front Oncol. 2022. PMID: 36119537 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical